Comparison of the antitumor efficacy of transcatheter arterial chemoembolization with a miriplatin-iodized oil suspension and a cisplatin-iodized oil suspension for hepatocellular carcinoma

Hepatology Research

Volumn 43, Issue 10, 2013, Pages 1071-1077

  Ueda, Tatsuo ^a   Murata, Satoru ^a   Yasui, Daisuke ^a   Mine, Takahiko ^a   Kumita, Shinichiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cisplatin; Hepatocellular carcinoma; Miriplatin; Suspension; Transcatheter arterial chemoembolization

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CISPLATIN; CREATININE; DECARBOXYPROTHROMBIN; HEMOGLOBIN; IA CALL; IODINATED POPPYSEED OIL; MIRIPLATIN; PROTHROMBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER CONTROL; CHEMOEMBOLIZATION; CHEMOTHERAPY INDUCED ANEMIA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; FATIGUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER NECROSIS; LIVER NODULE; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SUSPENSION; THERAPY EFFECT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 84885051048     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12212     Document Type: Article

References (26)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
2. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37: 429-442.
3. Lopez PM, Villanueva A, Llovet JM. Systematic review: evidence-based management of hepatocellular carcinoma - an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 2006; 23: 1535-1547.
4. Llovet JM, Ricci S, Mazzaferro V etal.; SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390.
5. Llovet JM, Real MI, Montaña X etal. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-1739.
6. Lo CM, Ngan H, Tso WK etal. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171.
7. Ikeda M, Maeda S, Ashihara H, Nagahama H, Tanaka M, Sasaki Y. Transcatheter arterial infusion chemotherapy with cisplatin-lipiodol suspension in patients with hepatocellular carcinoma. J Gastroenterol 2010; 45: 60-67.
8. Okusaka T, Okada S, Ueno H etal. Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma. Oncology 2000; 58: 293-299.
9. Cammà C, Schepis F, Orlando A etal. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002; 224: 47-54.
10. Marelli L, Stigliano R, Triantos C etal. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007; 30: 6-25.
11. Yoshikawa M, Ono N, Yodono H, Uchida T, Nakamura H. Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma. Hepatol Res 2008; 38: 474-483.
12. Kishimoto S, Miyazawa K, Terakawa Y etal. Cytotoxicity of cis-[((1R, 2R)-1, 2-Cyclohexanediamine-N, N′) bis (myristato)]-platinum (II) suspended in lipiodol in a newly established cisplatin resistant rat hepatoma cell line. Jpn J Cancer Res 2000; 91: 1326-1332.
13. Kishimoto S, Noguchi T, Yamaoka T, Fukushima S, Takeuchi Y. In vitro cytotoxicity of cis[((1R, 2R)-1, 2-cyclohexanediamine-N, N′)bis(myristato)] platinum(II) suspended in lipiodol in rat hepatoma AH-109A cells and human tumor cell lines. Biol Pharm Bull 2000; 23: 487-491.
14. Wang Z, Zhou J, Fan J etal. Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth. Expert Opin Investig Drugs 2009; 18: 1595-1604.
15. Rathore R, Safran H, Soares G etal. Phase I study of hepatic arterial infusion of oxaliplatin in advanced hepatocellular cancer: a Brown University oncology group study. Am J Clin Oncol 2010; 33: 43-46.
16. Uhm JE, Park JO, Lee J etal. A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma. Cancer Chemother Pharmacol 2009; 63: 929-935.
17. Okusaka T, Kasugai H, Ishii H etal. A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma. Invest New Drugs 2012; 30: 2015-2025.
18. Kudo M, Kubo S, Takayasu K etal. Response evaluation criteria in cancer of the liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 revised version). Hepatol Res 2010; 40: 686-692.
19. Yamamoto K, Shimizu T, Narabayashi I. Intraarterial infusion chemotherapy with lipiodol-CDDP suspension for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2000; 23: 26-39.
20. Ueda T, Murata S, Mine T etal. Comparison of epirubicin-iodized oil suspension and emulsion for transcatheter arterial chemoembolization in VX2 tumor. ScientificWorldJournal 2012; 2012: 961986.
21. Mine T, Murata S, Ueda T etal. Comparative study of cisplatin-iodized oil suspension and emulsion for transcatheter arterial chemoembolization of rabbit VX2 liver tumors. Hepatol Res 2012; 42: 473-481.
22. Okabe K, Beppu T, Haraoka K etal. Safety and short-term therapeutic effects of miriplatin-lipiodol suspension in transarterial chemoembolization (TACE) for hepatocellular carcinoma. Anticancer Res 2011; 31: 2983-2988.
23. Watanabe S, Nitta N, Ohta S etal. Comparison of the anti-tumor effects of two platinum agents (Miriplatin and Fine-Powder Cisplatin). Cardiovasc Intervent Radiol 2012; 35: 399-405.
24. Shibata J, Fujiyama S, Sato T, Kishimoto S, Fukushima S, Nakano M. Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer 1989; 64: 1586-1594.
25. Demachi H, Matsui O, Abo H, Tatsu H. Simulation model based on non-Newtonian fluid mechanics applied to the evaluation of the embolic effect of emulsions of iodized oil and anticancer drug. Cardiovasc Intervent Radiol 2000; 23: 285-290.
26. Bracard S, Macho-Fernández JM, Wang X, Anxionnat R, Picard L. Influence of temperature on embolisation with cyanoacrylate. Interv Neuroradiol 1998; 4: 301-305.